1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Bristol-myers Squibb Company (BMY) EVP, Research & Early Dev. Rupert Vessey Sold $3.5 million of Shares

November 23, 2020 | About:

EVP, Research & Early Dev. of Bristol-myers Squibb Company (30-Year Financial, Insider Trades) Rupert Vessey (insider trades) sold 57,591 shares of BMY on 11/19/2020 at an average price of $61.3 a share. The total sale was $3.5 million.

Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals. Bristol-Myers Squibb Company has a market cap of $139.92 billion; its shares were traded at around $61.92 with and P/S ratio of 3.47. The dividend yield of Bristol-Myers Squibb Company stocks is 2.91%. Bristol-Myers Squibb Company had annual average EBITDA growth of 1.80% over the past ten years. GuruFocus has detected 3 severe warning signs with Bristol-Myers Squibb Company. .

Directors and Officers Recent Trades:

  • EVP, Research & Early Dev. Rupert Vessey sold 57,591 shares of BMY stock on 11/19/2020 at the average price of $61.3. The price of the stock has increased by 1.01% since.

For the complete insider trading history of BMY, click here


Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by insider

User Generated Screeners

pascal.van.garsseHigh FCF-M2
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)